Riken To Apply For Govt Permission To Conduct IPS Clinical Research

TOKYO (Kyodo)--Japan's state-backed scientific research institute Riken said Thursday it has decided to apply for government permission for its plan to conduct clinical research using induced pluripotent stem cells, known as iPS cells, to regenerate retina.